5-OH-Tryptophane in migraine: clinical and neurophysiological considerations

J Neurol. 1981;225(1):41-6. doi: 10.1007/BF00313460.

Abstract

The clinical effects of the protracted treatment with 5-OH Tryptophane (5-HTP) of some patients with chronic migraine are compared with other patients with acetylsalicylic acid. The pain threshold was neurophysiologically determined in migraneous on patients whose response to 5-HTP therapy was specially good. The results with 5-HTP can be accounted for by an action of the substance on the serotonin turnover with activation of the serotoninergic antinociceptive system.

Publication types

  • Comparative Study

MeSH terms

  • 5-Hydroxytryptophan / pharmacology
  • 5-Hydroxytryptophan / therapeutic use*
  • Adult
  • Aspirin / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Migraine Disorders / drug therapy*
  • Nociceptors / drug effects

Substances

  • 5-Hydroxytryptophan
  • Aspirin